SCHEMBL14671702

SCHEMBL14671702

COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C(F)=CN(C)C

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 17/20 0.82
ERBB2 P04626 10/20 0.82
ERBB4 Q15303 4/20 0.82
PDGFRB P09619 2/20 0.82
ABL1 P00519 1/20 0.82
SRC P12931 1/20 0.82
PDGFRA P16234 1/20 0.82
FLT3 P36888 1/20 0.82
ERBB3 P21860 1/20 0.73
DUS2 Q9NX74 1/20 0.73
HDAC3 O15379 2/20 0.66
HDAC4 P56524 2/20 0.66
HDAC1 Q13547 2/20 0.66
HDAC7 Q8WUI4 2/20 0.66
HDAC2 Q92769 2/20 0.66
HDAC10 Q969S8 2/20 0.66
HDAC11 Q96DB2 2/20 0.66
HDAC8 Q9BY41 2/20 0.66
HDAC6 Q9UBN7 2/20 0.66
HDAC9 Q9UKV0 2/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15876899 0.90 EGFR (1.00) EGFRERBB2ERBB4PDGFRBABL1
SCHEMBL15876902 0.90 EGFR (1.00) EGFRERBB2ERBB4PDGFRBABL1
SCHEMBL15876900 0.90 EGFR (1.00) EGFRERBB2ERBB4PDGFRBABL1
SCHEMBL14671647 0.88 EGFR (0.77) EGFRERBB2ERBB4PDGFRBABL1
SCHEMBL14671617 0.88 EGFR (0.71) EGFRERBB2ERBB4PDGFRBABL1
SCHEMBL15877088 0.87 EGFR (0.85) EGFRERBB2ERBB4PDGFRBABL1
SCHEMBL15877086 0.87 EGFR (0.85) EGFRERBB2ERBB4PDGFRBABL1
SCHEMBL14671641 0.86 EGFR (0.86) EGFRERBB2ERBB4ABL1SRC
SCHEMBL15877129 0.86 EGFR (0.83) EGFRERBB2ERBB4PDGFRBABL1
SCHEMBL15877080 0.86 EGFR (0.81) EGFRERBB2ERBB4PDGFRBABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013013640-A1 QUINAZOLINE DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE, COMPOSITION AND APPLICATION THEREOF 上海医药集团股份有限公司 (CN) 2013-01-31 WO disclosed